Gene therapy for leukemia
Tweaking immune cells to attack cancer cells in leukemia patients can bring about remission, a small study shows. Scientists at the University of Pennsylvania genetically altered immune T cells to target malignant cells in chronic lymphocytic leukemia patients and mass produced the T cells before injecting them into three patients.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.